Why Invest?

AC Immune’s experienced team is pioneering diagnosis and treatment of neurodegenerative diseases, the largest unmet need in healthcare. Our discovery technologies and product-candidates have been validated by leading pharmaceutical companies and renowned specialist investors. Our leadership’s proven business strategy, which has monetized several product-candidates early to reduce risk and dilution, has generated about as much funding from partners as we have received from investors. The company has multiple near and mid-term value-creating milestones.